The impact of inoculum size on the activity of cefoperazone-sulbactam against multidrug resistant organisms

doi:10.1016/j.jmii.2017.08.026

Chia Nan University of Pharmacy & Science Institutional Repository > 藥理學院 > 保健營養系(所) > 期刊論文 > Item 310902800/32208

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/32208

標題:	The impact of inoculum size on the activity of cefoperazone-sulbactam against multidrug resistant organisms
作者:	Chang, Ping-Chin Chen, Chi-Chung Lu, Ying Chen Lai, Chih-Cheng Huang, Hui-Ling Chuang, Yin-Ching Tang, Hung-Jen
貢獻者:	Chi Mei Med Ctr, Dept Internal Med Chi Mei Med Ctr, Dept Med Res Natl Chiayi Univ, Dept Food Sci Chi Mei Med Ctr, Dept Intens Care Med Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr Chi Mei Med Ctr, Dept Med
關鍵字:	Cefoperazone-sulbactam Extended-spectrum beta-lactamases Escherichia coli Klebsiella pneumoniae Inoculum size
日期:	2018-04
上傳時間:	2019-11-15 15:45:14 (UTC+8)
出版者:	ELSEVIER TAIWAN
摘要:	Objectives: This study aims to assess the in vitro activity of cefoperazone alone and different cefoperazone-sulbactam ratios against different inoculum sizes of multidrug resistant organisms. Methods: Minimum inhibitory concentrations (MICs) of cefoperazone, cefoperazone-sulbactam at fixed ratio of 1: 1 and 2: 1 against a normal inoculum size of 5 x 10(5) CFU/ml and a high inoculum size of 5 x 10(7) CFU/ml were measured. Results: Each 33 isolates of extended-spectrum beta-lactamases (ESBL)-producing Escherichia coli, ESBL-producing Klebsiella pneumoniae, carbapenem-resistant E. coli, and carbapenem-resistant Pseudomonas aeruginosa and a total of 122 isolates of carbapenem-resistant Acinetobacter baumannii were collected. After the addition of sulbactam at a 1: 1 ratio, most MIC50 and MIC90 values decreased. Cefoperazone-sulbactam at a 1: 1 ratio had a higher susceptibility rate against ESBL-producing E. coli, carbapenem-resistant E. coli, and carbapenem-resistant A. baumannii than cefoperazone-sulbactam at a 2: 1 ratio (all P < 0.05). For ESBL-producing E. coli, the susceptibility rate of cefoperazone-sulbactam at ratios of (1: 1) and (2: 1) decreased from 97.0 to 87.9% and 90.9 to 60.6%, for normal to high inoculum, respectively. For ESBL-producing K. pneumoniae, both susceptibility rate of cefoperazone-sulbactam at ratios of (1: 1) and (2: 1) decreased from 75.8%, and 63.6% at normal inoculum to 51.5% and 42.4% at high inoculum. Conclusions: Cefoperazone-sulbactam at a 1: 1 ratio has greater in vitro activity against most multidrug resistant organisms than cefoperazone-sulbactam at a 2: 1 ratio. Such combinations were not influenced by the inoculum size of ESBL-producing E. coli and K. pneumoniae and could be a therapeutic option for treating severe infections. Copyright (C) 2017, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
link:	http://dx.doi.org/10.1016/j.jmii.2017.08.026
關聯:	Journal of Microbiology Immunology and Infection, v.51, n.2, pp.207-213
显示于类别:	[保健營養系(所) ] 期刊論文

文件中的档案:

档案	描述	大小	格式	浏览次数
10.1016-j.jmii.2017.08.026.pdf		406Kb	Adobe PDF	330	检视/开启
index.html		0Kb	HTML	1117	检视/开启

在CNU IR中所有的数据项都受到原著作权保护.

TAIR相关文章

数据加载中.....